Research found that 40% of African-Americans have a genetic variant that protects them from heart failure and prolongs their lives. The variant has an effect similar to beta blockers, which are widely prescribed for heart failure. This study resolves the controversy surrounding beta blocker efficacy in African-American patients.
The Centers for Medicare and Medicaid Services will solicit public input on establishing a HCPCS code for medicinal maggots. Medical maggots have been used in the US for over 80 years and can save thousands of dollars in medical costs, but CMS has not provided reimbursement codes.
A genetic variation found predominantly in African Americans acts as a natural 'beta-blockade', protecting against death and the need for a heart transplant. The discovery adds to evidence that genetic differences influence medication response, highlighting potential for personalized medicine.
Chronic inflammation in mice triggers cell fusions between blood cells and Purkinje neurons up to 100 times more frequently than previously believed. These fused cells, called heterokaryons, may play a role in protecting neurons against damage and offer new avenues for gene therapy.
Researchers at the University of Georgia have developed a sensitive method to test and assess drug treatments for Chagas disease. The study found that the current drug therapies can only cure the infection in less than 50% of those treated, but also identified a potential new treatment approach.